Drug intelligence / Profile preview

Vernivia

Development stage
Unknown
Lead developer
Pharmiva
Modality
Device-based Delivery → Drug Delivery Systems
Administration
Vaginal
01

Overview

**Vernivia** is a CE-certified, over-the-counter, antibiotic-free vaginal mousse developed for the treatment of **bacterial vaginosis**, a common vaginal infection caused by an imbalance in the vaginal flora[2][3][5]. Vernivia's unique mousse formulation enables effective distribution and rapid symptom relief (often within 12 hours), with curative effect demonstrated in clinical studies. Unlike antibiotic treatments, Vernivia does **not contribute to antimicrobial resistance** and does not lead to secondary fungal infections. The product is based on Pharmiva's proprietary Venerol drug delivery platform, designed to restore normal vaginal flora and support the body's natural defenses[3]. It is marketed primarily in Sweden and Europe, with ongoing clinical and real-world studies supporting its efficacy and safety[3][5][7].

Brand names
Vernivia
Other names
D005 Vaginal MousseD-005 Vaginal MousseD 005 Vaginal Mousse

Beyond the preview

Go deeper on Vernivia.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Vernivia.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call